Course director: Prof. Dr. Zoltán Kaló
4-day course in pharmaceutical research and development (2 credits)
Date: 13-16 January 2026, 9:00 AM – 4:00 PM
Location: Beznák Aladár Lecture Hall, Basic Medical Science Center, Semmelweis University
|
Day 1 |
Pharmaceutical R&D trends |
Zoltán Kaló |
|
Economic modelling of investigational health technologies (case study) |
Balázs Nagy |
|
|
Day 2 |
Principles of pharmaceutical pricing |
Zoltán Kaló |
|
Strategic pricing of investigational health technologies |
||
|
Strategic pricing in multiple indications (case study) |
||
|
Day 3 |
Importance of return on investment calculations in R&D decisions |
Zoltán Kaló |
|
Net present value calculation (case study) |
||
|
Day 4 |
Early phase assessment of non-pharmaceutical technologies |
Zoltán Kaló |
|
Fundraising for investigational health technologies |
Bertalan Jászkúti |
Technical requirements: participants should bring their own computer
Early Phase Health Technology Assessment COURSE
organised by the
Center for Health Technology Assessment,
SEMMELWEIS UNIVERSITY, Budapest
COURSE DATE: 13 – 16 January 2026, 9 AM-4 PM
Health economic aspects of pharmaceutical R&D decisions

For Whom?
For representatives of health care innovators, investors and payers, HTA agencies, academic researchers and market access specialists of the health care industry or who are involved or interested in-, or influenced by decisions in pharmaceutical research and development.
Brief description
Early phase assessment of investigational medical technologies requires special skills in health technology assessment, economic modeling, and market research. Innovators or funders should explore policy relevant value propositions, realistic pricing assumptions and market potential before moving ahead or investing in a development program. The course – in addition to providing insights into theory – will mainly be based on case studies. Participants will construct economic models to judge the value-based price of investigational medical technologies, and evaluate their expected net present value to support indication selection and go, no-go decisions.
Lecturers:

Prof. Dr. Zoltán Kaló Assoc. Prof. Balázs Nagy Bertalan Jászkúti
For more information, please download our detailed brochures from here:
Health Economics_Pharmaceutical RD Flyer_Jan_2026
Language: English only
Timing: Courses start at 9 AM, end at 4 PM
Skill requirements: Basic knowledge of statistics and/or pharmaceutical R&D, familiarity with MS Excel.
Equipment requirements: own laptop, MS Excel
Course fees*
- Faculty members and PhD students of Semmelweis University: Free
- Public & academic sector: 800 €
- Private sector: 1200 €
- download our application form: Registration_form_2026
- fill out the form,
- send the completed form in a .pdf format to hta@semmelweis.hu via email.
Important: After sending your registration form by email, please wait for receiving your invoice first. Only after you received your invoice transfer the registration fee.
Thank you!